Leadership Overview
EMS Pharma has 5 executives leading key functions including strategy, finance, and operations.
Driven by a commitment to health, EMS Pharma distributes pharmaceuticals across Brazil, upholding a legacy of quality and accessibility since its founding in 1950.
Driven by a commitment to health, EMS Pharma distributes pharmaceuticals across Brazil, upholding a legacy of quality and accessibility since its founding in 1950.
Leadership Roles at EMS Pharma
Omar Sabri - Chief Executive Officer
Omar Sabri, the Chief Executive Officer at EMS Pharma, directs the company's overarching strategy and operational framework. Sabri guides the organization's expansion and market positioning within the Brazilian pharmaceutical distribution sector. This leadership involves aligning departmental objectives with the company's mission to provide accessible healthcare solutions. Overseeing critical business development initiatives, Omar Sabri ensures the company maintains its competitive edge and adapts to evolving market demands. The Chief Executive Officer's purview encompasses fostering innovation and driving sustainable growth across all facets of the pharmaceutical distribution network. Sabri's strategic direction is fundamental to EMS Pharma's continued success and its role as a key distributor in Brazil.
Gustavo Bizinelli - Chief Financial Officer
Gustavo Bizinelli, the Chief Financial Officer at EMS Pharma, manages all financial operations and fiscal strategy. Bizinelli oversees budgeting, financial planning, and risk management, ensuring the company's fiscal health and compliance with regulatory standards in Brazil. This role is crucial for maintaining the financial stability required for pharmaceutical distribution. The Chief Financial Officer analyzes financial data to inform strategic decisions and optimize resource allocation across the organization. Gustavo Bizinelli's expertise supports the company's growth objectives by securing funding and managing investments effectively. Bizinelli's stewardship of financial resources is vital for EMS Pharma's operational continuity and expansion efforts.
Carl Meares - President
Carl Meares, the President at EMS Pharma, spearheads key operational initiatives and strategic partnerships. Meares drives the execution of business plans, focusing on enhancing the efficiency of pharmaceutical distribution channels throughout Brazil. This leadership position involves overseeing departmental performance and ensuring seamless integration of services. The President's responsibilities include fostering a culture of excellence and accountability within the operational teams. Carl Meares's strategic oversight contributes directly to the company's ability to meet market demands and expand its reach. Meares's focus on operational optimization is critical for EMS Pharma's sustained market presence and distribution capabilities.
Rex Crater - President
Rex Crater, the President at EMS Pharma, directs strategic market development and expansion efforts. Crater focuses on identifying new opportunities and strengthening the company's distribution network across Brazil. This role involves cultivating relationships with key stakeholders and ensuring alignment with corporate objectives. The President's leadership is instrumental in navigating the complexities of the pharmaceutical market. Rex Crater's strategic vision guides the company's growth trajectory and enhances its competitive positioning. Crater's dedication to market penetration is essential for EMS Pharma's ongoing success and its commitment to pharmaceutical accessibility.
Ken Krasko - President
Ken Krasko, the President at EMS Pharma, oversees critical aspects of supply chain management and logistical operations. Krasko ensures the efficient and timely delivery of pharmaceuticals across Brazil, adhering to stringent quality and safety standards. This position demands meticulous attention to detail in managing inventory and distribution networks. The President's role involves optimizing operational workflows to enhance service delivery and customer satisfaction. Ken Krasko's expertise in logistics is vital for maintaining EMS Pharma's reputation for reliability. Krasko's focus on operational excellence underpins the company's ability to serve the healthcare needs of the Brazilian population.
Explore Leadership Teams in Manufacturing
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.
Company Leadership
PC

Sandoz Group AG (SIX: SDZ) is a global healthcare company focused on developing, manufacturing, and delivering high-quality generic medicines and biosimilars. Serving patients worldwide, Sandoz provides treatments across multiple therapeutic areas, including oncology, immunology, and cardiovascular health.
Company Leadership AJ
EM
BE
BP
诺诚健华 is focused on developing innovative drugs to address significant unmet clinical needs in the fields of malignant tumors and autoimmune diseases. The company possesses comprehensive research and commercialization capabilities, aiming to create first-in-class or best-in-class therapies for global markets. With a strong pipeline in hematological malignancies, autoimmune diseases, and solid tumors, 诺诚健华 is committed to delivering high-quality innovative medicines that benefit patients worldwide. The company is led by co-founder and CEO Dr. 崔霁松, who emphasizes the importance of scientific-driven innovation.
Company Leadership NB
KG
SZ
Headquartered in Woodbury, Minnesota, Kindeva Drug Delivery is a leading global contract development and manufacturing organization (CDMO) in the pharmaceutical industry. Kindeva provides unique technologies and quality services to its customers, ranging from formulation and product development to commercial manufacturing. Kindeva focuses on complex drug programs, and its current offering spans inhalation drug delivery, transdermal drug delivery, microstructured transdermal systems (microsystems), and connected drug delivery.
Company Leadership BS
MC

DS